Adjuvants in cutaneous vaccination: A comprehensive analysis

Area of Science:

• Immunology
• Dermatology
• Vaccinology

Background:

• Skin acts as a barrier and houses immune cells like antigen-presenting cells (APCs).
• Skin vaccination routes can activate APCs, leading to adaptive immune responses.
• Adjuvants enhance vaccine immunogenicity and therapeutic efficacy.

Purpose of the Study:

• To review preclinical and clinical studies on skin vaccine delivery with adjuvants.
• To discuss FDA-approved adjuvants, their use, challenges, and regulatory concerns.
• To explore the future prospects of adjuvant-containing vaccines delivered via skin.

Main Methods:

• Literature review of preclinical and clinical studies.
• Focused discussion on FDA-approved adjuvants.
• Analysis of challenges and regulatory aspects of adjuvant use.

Main Results:

• Skin vaccine delivery offers reliable antigen delivery, superior immunogenicity, and convenience.
• Adjuvants significantly augment immune responses to vaccine antigens.
• Various skin routes have shown promise for vaccine administration.

Conclusions:

• Adjuvant-containing vaccines delivered via skin demonstrate significant potential.
• Understanding adjuvant mechanisms and regulatory landscapes is crucial for development.
• Future research should focus on optimizing skin delivery systems and adjuvant combinations.